April 2018
-
Using Deep Learning Systems to Radiologically Predict Pathologic Invasiveness in Lung Adenocarcinoma
By Masahiro Yanagawa, MD, PhD, andNoriyuki Tomiyama, MD, PhD Posted: April 2018 Improvement in computer capacity, the expansion of computer networks, and the emergence of big data have resulted in […]
-
PACIFIC Trial Leads to Durvalumab Approval in United States
The U.S. Food and Drug Administration approved durvalumab on February 16, 2018, for the treatment of patients with stage III NSCLC whose tumors are unresectable and whose cancer has not […]
-
Management of Pulmonary Nodules Detected by CT Screening
By Annemie Snoeckx, MD, andPaul E. Van Schil, MD, PhD Posted: April 2018 No universally accepted guidelines or management protocols exist for diagnosis and treatment of screen-detected nodules. Radiologic management […]
-
Barriers to Access to New Lung Cancer Drugs in Latin America
By Pedro N. Aguiar Jr., MD, MSc, andGilberto L. Lopes Jr., MD, MBA Posted: April 2018 After often-painful but effective and still incomplete economic reforms, more rational government spending, and […]
View ILCN Archives
Provider Resources